The #MedSafetyWeek campaign, first launched in 2016, seeks to educate the public on why, how, and where to report suspected side effects of medicines and vaccines. Background Since 2016, Uppsala Monitoring Centre has teamed up with pharmacovigilance and patient safety stakeholders worldwide for #MedSafetyWeek – a campaign to raise awareness and encourage reporting of side effects. Uppsala Monitoring Centre (UMC) is an independent, self-funded, non-profit foundation established in 1978, dedicated to safer use of medicines and vaccines. Through an agreement between the Government of Sweden and the World Health Organization (WHO), UMC operates the WHO Programme for International Drug Monitoring (PIDM), supporting over 180 member countries and regions in strengthening safety surveillance. Theme for 2025 The 2025 edition, marking the tenth anniversary of the campaign. The 2025 campaign is during 3 to 9 November 2025. The theme revolves around how we can all help make medicines safer. This year’s campaign carried the core message: “Everyone has a role to play in medicines safety. By reporting suspected side effects, you and I can help make medicines safer for everyone.” The initiative aimed to raise awareness among patients, families, and healthcare professionals about the importance of reporting suspected side effects of medicines. Source : WHO-UMC National Coordination Centre-Pharmacovigilance Programme of India The National Coordination Centre-Pharmacovigilance Programme of India (PvPI), Indian Pharmacopoeia Commission, Ministry of Health and Family Welfare, Government of India was launched as a WHO Collaborating Centre for Pharmacovigilance in Public Health Programmes and Regulatory Services on 30 October 2017. The mission of PvPI is to safeguard the health of the Indian population by ensuring that the benefit of use of medicine outweighs the risks associated with its use. Healthcare professionals (HCPs) and patients are encouraged to report adverse events due to pharmaceutical products (if any) to their preferred ADRs monitoring centre. Application form for reporting of Suspected Adverse Drug Reaction by Healthcare Professionals Application form for reporting of Suspected Adverse Drug Reaction by patients Helpline Number Managed by NCC PvPI to provide assistance in ADRs reporting for the HCPs and general public: 1800 180 3024 (All Working Days 9:00 AM to 5:30PM) Source : NCC, PvPI